Abstract
Use of reconstituted lyophilized protein based materials in the clinical laboratory is partly based on the assumption that these materials adequately simulate patients' sera. We examined several of these materials and found that certain ones do not have the same absorbancies at 340 and 380 nm as do most sera. The implication of this is examined with respect to glucose determination by the hexokinase method on a dual wave length blank subtraction instrument.
| Original language | English |
|---|---|
| Pages (from-to) | 1812-1814 |
| Number of pages | 3 |
| Journal | Clinical Chemistry |
| Volume | 21 |
| Issue number | 12 |
| State | Published - Dec 1 1975 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Clinical Biochemistry
Cite this
An example of lyophilized protein based materials not simulating patient sera. / Steele, Bernard W; Koehler, D. F.; Blaszkowski, T. P.; Azar, M.
In: Clinical Chemistry, Vol. 21, No. 12, 01.12.1975, p. 1812-1814.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An example of lyophilized protein based materials not simulating patient sera
AU - Steele, Bernard W
AU - Koehler, D. F.
AU - Blaszkowski, T. P.
AU - Azar, M.
PY - 1975/12/1
Y1 - 1975/12/1
N2 - Use of reconstituted lyophilized protein based materials in the clinical laboratory is partly based on the assumption that these materials adequately simulate patients' sera. We examined several of these materials and found that certain ones do not have the same absorbancies at 340 and 380 nm as do most sera. The implication of this is examined with respect to glucose determination by the hexokinase method on a dual wave length blank subtraction instrument.
AB - Use of reconstituted lyophilized protein based materials in the clinical laboratory is partly based on the assumption that these materials adequately simulate patients' sera. We examined several of these materials and found that certain ones do not have the same absorbancies at 340 and 380 nm as do most sera. The implication of this is examined with respect to glucose determination by the hexokinase method on a dual wave length blank subtraction instrument.
UR - http://www.scopus.com/inward/record.url?scp=0016584738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016584738&partnerID=8YFLogxK
M3 - Article
C2 - 1183005
AN - SCOPUS:0016584738
VL - 21
SP - 1812
EP - 1814
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 12
ER -